Company News

Wipro's long wait for a turnaround continues after more than a decade

Srini Pallia, the insider leading the company, is focusing on large deals to boost revenue

Legal battle over Yes Bank AT1 bond write-off reaches Supreme Court

The dispute stems from the 2020 reconstruction of Yes Bank, when Rs 8,400 crore of AT1 bonds were written down as part of the RBI-led rescue plan

CAG calls for closer ties with CCI to protect markets and public funds

Comptroller and Auditor General Sanjay Murthy said audit findings and competition enforcement must work together to safeguard public finances and ensure market integrity

Kalpataru Projects eyes ₹30K cr orders in FY27 amid expansion push

The EPC company plans to expand into solar and nuclear sectors while targeting higher revenue growth and margin improvement in FY27

Samsung reaches tentative labour union deal, averting crippling strike

Samsung Electronics reaches tentative wage deal with union, easing fears of major semiconductor supply disruptions

SC says fake citations issue in Essel insolvency case under review

The Supreme Court said concerns over allegedly fake judicial precedents cited in the Essel Infraprojects insolvency case were being examined administratively by a committee

Oil India exploring overseas asset acquisition, says CMD Ranjit Rath

The state-run upstream company is exploring overseas assets across multiple geographies while expanding domestic exploration and deepwater partnerships

CCI okays Blackstone, investors' stake acquisition offer in Neysa Networks

Competition Commission of India clears Blackstone-backed investment in AI cloud firm Neysa Networks

Axis Pension Fund targets 500K new subscribers and ₹30,000 crore AUM

The pension fund manager expects onboarding through BHIM, Google Pay and PhonePe, along with new products, to drive subscriber growth in FY27

James Murdoch to buy half of Vox Media in deal exceeding $300 million

James Murdoch expands his US media footprint with a major stake in Vox Media and its podcast network

Eurobank opens India office, enables UPI-based remittance service

The Athens-headquartered lender will become the first European bank to enable cross-border remittances to India through the UPI framework

Dr Reddy's unveils oral diabetes drug Obeda for type 2 patients in India

The once-daily prescription tablet for type 2 diabetes received CDSCO approval after a Phase III trial showed comparable efficacy and safety to the innovator drug

CloudExtel eyes acquisitions worth ₹1,500-2,000 crore over five years

Macquarie-backed telecom infrastructure firm plans to acquire smaller cable operators and niche firms as it expands its network-as-a-service and data-centre connectivity business

Aditya Birla Capital raises ₹4,000 cr in equity capital from promoters, IFC

The Aditya Birla Group's financial services arm will use the capital raised from promoters and IFC to strengthen lending businesses and accelerate digital growth initiatives

NephroPlus sharpens global dialysis push as overseas business grows

NephroPlus said overseas markets now contribute nearly 42 per cent of revenue as the dialysis provider expands globally through acquisitions, PPP projects and clinic additions

More output, fewer workers: Why are labour-heavy industries becoming leaner

Rising production, ageing workforces, and rapid automation are pushing India's industrial companies towards leaner, productivity-driven workforce structures

IMFA bets on ferro chrome expansion, renewables for next growth phase

IMFA is expanding ferro chrome capacity, scaling renewable energy use, and exploring critical minerals as it prepares for the next phase of growth

PepsiCo India to invest ₹5,700 crore in expansion plans till 2030

PepsiCo India plans major investments in manufacturing and regional expansion as it sees strong growth potential in India's food and beverage market

BPCL plans ₹25,000 crore capex for FY27, calls fuel price hike respite

State-run oil major says recent increase in retail fuel prices has eased pressure amid soaring crude prices and mounting under-recoveries

HAB Pharma targets ₹3,000 crore revenue by 2030 after merger deal

HAB Pharmaceuticals aims to scale operations and expand globally after merging with Signature Phytochemical Industries through a slump sale deal